Tammy T. Brown
FDA investigator
Appears on 2 documents from 2026, mostly at sites in Florida. Most often cites control of microbiological contamination (21 CFR 211.113).
- 2
- Documents on file
- 4.5
- Observations per 483
- 2026
- First seen
- 2026
- Most recent
What they cite most
From 9 observations- 21 CFR 211.113Control of microbiological contamination2
- 21 CFR 211.84(b)Testing and approval or rejection of components, drug product containers, and closures2
- 21 CFR 211.100(a)Written procedures; deviations1
- 21 CFR 211.22Responsibilities of quality control unit1
- 21 CFR 211.52Washing and toilet facilities1
- 21 CFR 211.58Maintenance1
Activity by year
2026: 2
Where
Florida 2
Often inspects with
Is Tammy T. Brown coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2026-02-26 | 483 CoreRX Inc. DBA Bend BioscienceFeb 26, 2026 · Clearwater, Florida | Clearwater, Florida | 7 | |
| 2026-01-30 | 483 Catalent Pharma Solutions, LLCJan 30, 2026 · Saint Petersburg, Florida | Saint Petersburg, Florida | 2 |
About this profile
What does Tammy T. Brown inspect?
Tammy T. Brown appears on 2 documents on file covering 2 sites, mostly in Florida.
What do they cite most often?
21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.84(b) and 21 CFR 211.100(a).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Tammy T. Brown is dated Feb 26, 2026.